Increase in Prevalence of Psoriatic Arthritis Expected to Drive Psoriatic Arthritis Treatment Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit The Psoriatic arthritis is a joint disease associated to psoriasis it affects the skin and musculoskeletal system. It is caused by genetic and environmental factors. Some of the key symptoms include swollen toes, fingers, and tender joints, lowered back pain, pitted nails, and stiffness of psoriatic arthritis. Diagnosis of the psoriatic arthritis is largely done by the tests associated to joint fluid test, X-ray, rheumatoid factor (RF), and magnetic resonance imaging (MRI). Psoriatic arthritis is majorly treated with the drug such as NSAIDs, disease-modifying antirheumatic drugs (DMARDs), biologics, and immunosuppressant drugs. According to study, “Psoriatic Arthritis Treatment Market by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type (Prescription, and OTC), and Route of Administration (Topical, Oral, and Injectable): Global Opportunity Analysis and Industry Forecast, 2019-2026”. Some of the key companies operating in the global psoriatic arthritis treatment market are Amgen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Celgene Corporation, Johnson & Johnson, Eli Lilly And Company, Merck & Co Inc., Pfizer Inc., Novartis AG, and UCB S.A. Strategic initiatives including mergers and acquisitions, collaborations, partnerships, and joint ventures make a cumbersome market dynamics among the key players. Based on drug type, psoriatic arthritis treatment market is segmented into Disease Modifying Anti-Rheumatic Drugs(DMARDs), Nonsteroidal anti-inflammatory drugs (NSAIDs), biologics, and others. The biologics segment dominates the market owing to surge in adoption of biological therapies, rise in demand & higher acceptability for innovative therapies, and availability of generic biologic drugs. Based on type, market is segmented into Over-the-Counter (OTC) and prescription. In addition, based on route of administration, market is segmented into oral, topical, and injectable. The injectable segment is predictable to exhibit substantial growth rate due to surge in research & development (R&D) to develop novel drugs, rise in healthcare budgets of developed & developing countries, increase in awareness toward psoriatic arthritis treatment, reimbursement available for injectable drugs and increase in consumption of injectable psoriatic arthritis treatment drugs during the forecast period. The psoriatic arthritis treatment market is driven by increase in number of pipeline drugs, followed by rise in prevalence of psoriasis & psoriatic arthritis disease, increase in R&D activities to develop new products for effective treatment of psoriatic arthritis, surge in awareness toward availability of treatment for psoriatic arthritis, increase in risk of diseases, frequent product launches by key players and increase in government expenditure on healthcare. However, high cost of treatment and lack of standardization tools for diagnosis may impact the market. Moreover, based on geography, the North-American is a leading region in global psoriatic arthritis treatment market owing to commercial sales of products in the U.S., proactive government initiatives, presence of key manufacturers in the region. Whereas, the Asian-Pacific is anticipated to be one of the fastest-growing regions due to growth in economic development, increase in disposable income, improvement in healthcare infrastructure, and rise in consumer awareness over the forecast period. The psoriatic arthritis treatment market was valued at US $7,860 million in 2018, and is expected to reach at US $13,744 million by 2026, registering a CAGR of 7.2% from 2019-2026. For More Information, refer to below link:- Global Psoriatic Arthritis Treatment Market Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Abbott Laboratories Psoriatic Arthritis Treatment Market Revenue, AbbVie Psoriatic Arthritis Treatment Market Revenue, Amgen Psoriatic Arthritis Treatment Market Shares, Asia Pacific Psoriatic Arthritis Treatment Market, Australia Psoriatic Arthritis Treatment Market, Brazil Psoriatic Arthritis Treatment Market, Bristol-Myers Squibb Psoriatic Arthritis Treatment Market Size, Canada Psoriatic Arthritis Treatment Market, Celgene Corporation Psoriatic Arthritis Treatment Market Sales, China Psoriatic Arthritis Treatment Market, Covid-19 Impact on Global Psoriatic Arthritis Treatment Industry, Covid-19 Impact on Global Psoriatic Arthritis Treatment Market, Eli Lilly And Company Psoriatic Arthritis Treatment Market Shares, Europe Psoriatic Arthritis Treatment Market, F. Hoffmann-La Roche AG Psoriatic Arthritis Treatment Market Sales, France Psoriatic Arthritis Treatment Market, Germany Psoriatic Arthritis Treatment Market, Global Psoriatic Arthritis Treatment Biologics Market, Global Psoriatic Arthritis Treatment DMARDs Market, Global Psoriatic Arthritis Treatment Industry, Global Psoriatic Arthritis Treatment Industry Research Report, Global Psoriatic Arthritis Treatment Injectable Market, Global Psoriatic Arthritis Treatment Market, Global Psoriatic Arthritis Treatment Market Analysis, Global Psoriatic Arthritis Treatment Market Competition, Global Psoriatic Arthritis Treatment Market Forecast, Global Psoriatic Arthritis Treatment Market Future Outlook, Global Psoriatic Arthritis Treatment Market Growth, Global Psoriatic Arthritis Treatment Market Research Report, Global Psoriatic Arthritis Treatment Market Revenue, Global Psoriatic Arthritis Treatment Market Shares, Global Psoriatic Arthritis Treatment Market Size, Global Psoriatic Arthritis Treatment NSAIDs Market, Global Psoriatic Arthritis Treatment Oral Market, Global Psoriatic Arthritis Treatment OTC Market, Global Psoriatic Arthritis Treatment Prescription Market, India Psoriatic Arthritis Treatment Market, Industry Research Report Of Global Psoriatic Arthritis Treatment, Japan Psoriatic Arthritis Treatment Market, Johnson & Johnson Psoriatic Arthritis Treatment Market Size, LAMEA Psoriatic Arthritis Treatment Market, Marché mondial du traitement de l'arthrite psoriasique, Market Research Report Of Global Psoriatic Arthritis Treatment, Mercado global de tratamiento de artritis psoriásica, Merck & Co Psoriatic Arthritis Treatment Market Revenue, Mexico Psoriatic Arthritis Treatment Market, North America Psoriatic Arthritis Treatment Market, Novartis AG Psoriatic Arthritis Treatment Market Size, Pfizer Psoriatic Arthritis Treatment Market Sales, Psoriatic Arthritis Treatment Industry In Global, Psoriatic Arthritis Treatment Market In Global, Russia Psoriatic Arthritis Treatment Market, Saudi Arabia Psoriatic Arthritis Treatment Market, South Africa Psoriatic Arthritis Treatment Market, U.S. Psoriatic Arthritis Treatment Market, UCB S.A. Psoriatic Arthritis Treatment Market Revenue, Valeant Pharmaceuticals International Psoriatic Arthritis Treatment Market Size, Мировой рынок лечения псориатического артрита, السوق العالمية لعلاج التهاب المفاصل الصدفي, 世界の乾癬性関節炎治療市場, 全球银屑病关节炎治疗市场, 글로벌 건 선성 관절염 치료 시장